Financial results - REAL PHARMA CONSULTING S.R.L.

Financial Summary - Real Pharma Consulting S.r.l.
Unique identification code: 46434750
Registration number: J2022012984408
Nace: 7499
Sales - Ron
49.133
Net Profit - Ron
37.203
Employees
1
Open Account
Company Real Pharma Consulting S.r.l. with Fiscal Code 46434750 recorded a turnover of 2024 of 49.133, with a net profit of 37.203 and having an average number of employees of 1. The company operates in the field of Alte activităţi profesionale, stiinţifice şi tehnice n.c.a. having the NACE code 7499.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Real Pharma Consulting S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - 20.785 48.721 49.133
Total Income - EUR - - - - - - - 20.785 48.721 49.133
Total Expenses - EUR - - - - - - - 600 9.687 11.463
Gross Profit/Loss - EUR - - - - - - - 20.185 39.034 37.669
Net Profit/Loss - EUR - - - - - - - 19.922 38.670 37.203
Employees - - - - - - - 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 1.4%, from 48.721 euro in the year 2023, to 49.133 euro in 2024. The Net Profit decreased by -1.251 euro, from 38.670 euro in 2023, to 37.203 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Real Pharma Consulting S.r.l.

Rating financiar

Financial Rating -
REAL PHARMA CONSULTING S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Real Pharma Consulting S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Real Pharma Consulting S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Real Pharma Consulting S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Real Pharma Consulting S.r.l. - CUI 46434750

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - 0 0 0
Current Assets - - - - - - - 20.734 43.317 44.333
Inventories - - - - - - - 0 0 0
Receivables - - - - - - - 7.097 36.145 35.903
Cash - - - - - - - 13.637 7.172 8.430
Shareholders Funds - - - - - - - 19.962 39.231 37.974
Social Capital - - - - - - - 41 40 40
Debts - - - - - - - 772 4.109 6.538
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7499 - 7499"
CAEN Financial Year 7490
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 44.333 euro in 2024 which includes Inventories of 0 euro, Receivables of 35.903 euro and cash availability of 8.430 euro.
The company's Equity was valued at 37.974 euro, while total Liabilities amounted to 6.538 euro. Equity decreased by -1.038 euro, from 39.231 euro in 2023, to 37.974 in 2024.

Risk Reports Prices

Reviews - Real Pharma Consulting S.r.l.

Comments - Real Pharma Consulting S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.